Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
